Newly elected UC Staff Senate to hold inaugural meeting
UC staff can make their voices heard at Staff Senate meeting July 31
Event Information (passed)
New senate members were elected in early June, followed by the first senator orientation where the more than 45 new members gathered to form committees and prepare for their new role as the first elected staff senators.
The senate’s inaugural meeting will be held on July 31, from 10 a.m. to noon in TUC rooms 400 A, B & C, and the meeting is open to the public. All UC staff are encouraged to attend to make their voices heard.
More about:
Anyone may submit ideas and feedback online via the Staff Senate Suggestion Form or by emailing staffsenate@ucmail.uc.edu.
Save another date: Dec. 12, 2019
Staff Senate is planning a recognition and awards ceremony in December. More details will be forthcoming but all staff are encouraged to save the date.
Join the listserv for staff senate news or events. Go to the website and click on Join Staff Senate Listserv.
Tags
Related Stories
A jolly good trip: Bearcats take on London for fragrance company
May 15, 2026
Six NEXT Innovation Scholars at the University of Cincinnati traveled to London to transform field research into actionable recommendations for British luxury bath, body and fragrance brand Molton Brown.
UC Blue Ash celebrates top students and recognizes Honor Student of the Year
May 14, 2026
The University of Cincinnati Blue Ash College recently hosted a special event that celebrated students for exceptional achievements during the 2025-26 academic year. The honorees included academic award winners, student engagement award winners, Latin Honors graduates, and the 2026 UC Blue Ash College Honor Student of the Year.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.